2021
DOI: 10.1002/chir.23337
|View full text |Cite
|
Sign up to set email alerts
|

Regioselective asymmetric bioreduction of trans‐4‐phenylbut‐3‐en‐2‐one by whole‐cell of Weissella cibaria N9 biocatalyst

Abstract: There is a considerable interest in the asymmetric production of chiral allylic alcohols, the main building blocks of many functional molecules. The asymmetric reduction of α,β-unsaturated ketones is difficult with traditional chemical protocols in a regioselective and stereoselective manner. In this study, the reductive capacity of whole cell of Leuconostoc mesenteroides N6, Weissella paramesenteroides N7, Weissella cibaria N9, and Leuconostoc pseudomesenteroides N13 was investigated as whole-cell biocatalyst… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
11
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
5

Relationship

1
4

Authors

Journals

citations
Cited by 13 publications
(11 citation statements)
references
References 41 publications
0
11
0
Order By: Relevance
“…To achieve this, reaction conditions must be set up in such a manner that a reactant may be transported to catalytic sites with the maximum solubility in the reaction media, hence increasing the permeability of the cells to the reactant. The success of a biocatalytic process, in terms of yield and enantiomeric purity of the desired product, is dependent on both the accurate selection of the best performing biocatalyst and the optimization of reaction parameters 26 . First of all, to determine the biocatalyst with the best reducing capacity, six different biocatalysts were tested in the asymmetric reduction of substrate 1 (Table 1).…”
Section: Resultsmentioning
confidence: 99%
“…To achieve this, reaction conditions must be set up in such a manner that a reactant may be transported to catalytic sites with the maximum solubility in the reaction media, hence increasing the permeability of the cells to the reactant. The success of a biocatalytic process, in terms of yield and enantiomeric purity of the desired product, is dependent on both the accurate selection of the best performing biocatalyst and the optimization of reaction parameters 26 . First of all, to determine the biocatalyst with the best reducing capacity, six different biocatalysts were tested in the asymmetric reduction of substrate 1 (Table 1).…”
Section: Resultsmentioning
confidence: 99%
“…Chemical stereoselective methods are available for the synthesis of pure enantiomers of allylic alcohols, including reduction of prochiral ketones 8,12 and hydrogenation of enones 13 . However, these methods are not particularly practical due to the use of high temperatures and pressure and argon atmosphere; moreover, the catalytic process involves a metal ligand 5,12,13 …”
Section: Introductionmentioning
confidence: 99%
“…Their utility has been largely demonstrated in a variety of organic transformations, including the formation of carbon-carbon bonds and the addition of several functional groups into the double bond, incorporating other stereocenters through reactions of hydrogenation, epoxidation, and hydroboration, such as Simmons-Smith reaction. [1][2][3][4][5][6][7][8] Furthermore, optically active allylic alcohols can serve as building blocks in the synthesis of chiral lactones, such as 4-hydroxy-5-6-dihydropyrone, which has inhibitory activity against the HIV protease. 9,10 Beyond this, some allylic alcohols are used in the synthesis of enantiomerically pure hydroxy lactones, which exhibited high antifeedant activity against insects.…”
Section: Introductionmentioning
confidence: 99%
See 2 more Smart Citations